Literature DB >> 18255349

Patient predictors of esophageal stricture development after photodynamic therapy.

Patrick Yachimski1, William P Puricelli, Norman S Nishioka.   

Abstract

BACKGROUND & AIMS: The most common significant adverse event after photodynamic therapy (PDT) with porfimer sodium is esophageal stricture formation. This study assessed whether pretreatment variables, including prior endoscopic therapy for Barrett's esophagus, are associated with post-PDT stricturing.
METHODS: Data from all patients who had undergone PDT with porfimer sodium for Barrett's esophagus with high-grade dysplasia, intramucosal carcinoma, or T1 cancer at our institution since 1997 were reviewed.
RESULTS: One hundred sixteen patients underwent 160 courses of PDT. The incidence of stricture formation after index PDT was 16% (19/116). For all PDT courses, the overall incidence of stricture was 23% (37/160). Stricture rate was significantly higher after a second PDT course compared with index PDT (43% vs 16%, P = .0007). There was no association between post-PDT stricture development and age, gender, body mass index, or prior endoscopic mucosal resection. Patients who developed a stricture had a longer length of Barrett's esophagus before treatment than those who did not develop a stricture (7.7 vs 5.7 cm for index PDT only, P = .025; 7.4 vs 5.7 cm for all PDT courses, P = .007). Length of Barrett's esophagus, multiple PDT courses, and presence of intramucosal carcinoma on pretreatment pathology were independent predictors of post-PDT stricture in a stepwise logistic regression analysis controlling for treatment variables, including treatment length.
CONCLUSIONS: An increased risk of stricture development was seen after multiple courses of PDT. An association between post-PDT stricture and length of Barrett's esophagus but not treatment length was also found. Endoscopic mucosal resection did not appear to influence the likelihood of stricture development after porfimer sodium-based PDT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255349     DOI: 10.1016/j.cgh.2007.12.001

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  12 in total

1.  Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus.

Authors:  Kazuhiro Yasuda; Sung Eun Choi; Norman S Nishioka; David W Rattner; William P Puricelli; Angela C Tramontano; Seigo Kitano; Chin Hur
Journal:  Dig Dis Sci       Date:  2014-01-07       Impact factor: 3.199

2.  Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus.

Authors:  Jason J Lewis; Joel H Rubenstein; Amit G Singal; B Joseph Elmunzer; Richard S Kwon; Cyrus R Piraka
Journal:  Gastrointest Endosc       Date:  2011-08-05       Impact factor: 9.427

3.  Metal stenting to resolve post-photodynamic therapy stricture in early esophageal cancer.

Authors:  Young Koog Cheon
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

4.  Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.

Authors:  Patrick Yachimski; Mari Mino-Kenudson; Margaret E Sherwood; William P Puricelli; Norman S Nishioka; Gregory Y Lauwers
Journal:  Virchows Arch       Date:  2011-11-13       Impact factor: 4.064

5.  Safety of endoscopic mucosal resection for Barrett's esophagus.

Authors:  Yutaka Tomizawa; Prasad G Iyer; Louis M Wong Kee Song; Navtej S Buttar; Lori S Lutzke; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2013-07-16       Impact factor: 10.864

Review 6.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

7.  Barrett's esophagus: where do we stand?

Authors:  Majid A Al Madi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

8.  Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy.

Authors:  Patrick Yachimski; Norman S Nishioka; Ethan Richards; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-10       Impact factor: 11.382

Review 9.  Photodynamic Therapy for Cancer: What's Past is Prologue.

Authors:  Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2020-01-07       Impact factor: 3.421

Review 10.  Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.

Authors:  Devidas Menon; Tania Stafinski; Heng Wu; Darren Lau; Clarence Wong
Journal:  BMC Gastroenterol       Date:  2010-09-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.